Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Nursing Education Clinical Placements topic
No spam. Unsubscribe anytime.
Board opposes bill allowing out‑of‑state distance nursing programs to place students in California clinicals
Summary
The board voted unanimously to oppose Assembly Bill 1082, which would permit California clinical placements for residents enrolled in out‑of‑state distance prelicensure nursing programs accredited by a U.S. Department of Education‑recognized accreditor, citing program oversight and clinical impaction concerns.
The Board of Registered Nursing voted March 20 to oppose Assembly Bill 1082. The bill would allow California residents enrolled in prelicensure distance education nursing programs based at out‑of‑state private postsecondary institutions to conduct clinical experiences in California if the program is accredited by a programmatic accrediting agency recognized by the U.S. Department of Education and meets other conditions.
Board staff and members said the proposal raises two core concerns: oversight and clinical impaction. The board currently requires in‑state approval for nursing programs, and staff said board approval allows the BRN to monitor program outcomes, require corrective actions, and, if necessary, place programs on interim or closure statuses to protect students and the public. Under AB 1082, the board would have no approval authority over some out‑of‑state programs conducting clinicals in California.
Staff pointed to data showing the bill sponsor already enrolled thousands of California residents in out‑of‑state programs. Board members warned that large numbers of out‑of‑state students seeking clinical placements could displace in‑state students at clinical agencies, an effect known as clinical impaction. Staff also noted that accreditation alone does not substitute for state board approval and expressed concern about recent variability in pass rates for some sponsor schools.
After public comment and staff briefing, the board voted 5‑0 to oppose AB 1082. The board directed staff to include program oversight and clinical impaction arguments in its opposition letter and to reference accreditation oversight risks if federal accreditation oversight changes in the future.
